GENPACT Form 144: Insider Plans Sale of 9,744 Shares via Morgan Stanley
Rhea-AI Filing Summary
Form 144 notice indicates a proposed sale of 9,744 common shares through Morgan Stanley Smith Barney on 08/22/2025 with an aggregate market value of $443,352.00. The shares were acquired as restricted stock from the issuer on 01/10/2025 and paid for on that date. The filer disclosed two prior sales on 08/21/2025 totaling 18,218 shares for gross proceeds of $810,701.00 (listed as $505,119.50 and $305,581.50). The notice includes the standard representation that the seller does not possess undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Rule 144 filing showing disposition of restricted shares soon after acquisition; standard disclosure and broker routing.
This Form 144 documents a planned sale of 9,744 common shares via Morgan Stanley on 08/22/2025, acquired as restricted stock on 01/10/2025. The filing also reports two prior sales on 08/21/2025 totaling 18,218 shares for aggregate gross proceeds of $810,701.00. From a compliance perspective, the filer makes the customary representation about lack of undisclosed material information and provides broker details and sale timing, consistent with Rule 144 notice requirements. There is no indication in the form of trading-plan adoption or other special instructions.
TL;DR: Transaction appears administratively routine; volumes are small relative to large-cap public float and show immediate post-acquisition liquidity.
The notice identifies the sale method (Morgan Stanley Smith Barney) and specific share counts and proceeds for recent transactions. The securities were acquired as restricted stock from the issuer on 01/10/2025 and are being sold in August 2025. The form does not provide issuer operational or financial details; it focuses solely on share disposition mechanics and prior recent sales by the same person.